Delivery Order SPE2DR25D1202-SPE2DR26F77GX
Award Date 4/20/26
Potential Completion Date 4/21/26
Potential Value $19K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $14,002.39 delivery order to Amerisourcebergen Drug Corp on April 20, 2026, for Jardiance 25 mg tablets (90-count packages). The order is firm fixed price with a completion date of April 21, 2026. Place of performance is Conshohocken, PA. The order carries no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying brand-name and generic medications to Defense Health Agency and military...
- The Defense Logistics Agency issued a $94,495.96 delivery order to AmerisourceBergen Drug Corp on April 20, 2026, for Jardiance 25 mg tablets (90-count packages). The order ceiling is $94,495.96 with an ultimate completion date of April 21, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., and operates as a pharmaceutical distributor supplying brand-name and generic medications to Defense...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 17, 2026, for JARDIANCE 25 MG tablets (90-count package) with a firm fixed price of $19,986.62 and an ultimate completion date of February 18, 2026. Place of performance is Conshohocken, PA. The order was issued under the company's parent indefinite delivery contract with DLA Troop Support Medical, a comprehensive global pharmaceutical supply vehicle valued at up to $999,999,999.00 and running through...
- The Defense Logistics Agency issued a $43,355.14 delivery order to Amerisourcebergen Drug Corp on April 1, 2026, for JARDIANCE 25 mg tablets (90-count units). The order is issued under the DLA Troop Support Medical IDC, a $999,999,999.00 indefinite delivery contract through December 2026 that supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with an...
- <p>The Defense Logistics Agency issued a $2,021.18 delivery order to Amerisourcebergen Drug Corp on February 25, 2026, for JARDIANCE 10 MG tablets (90-count).</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 26, 2026, and carries firm fixed pricing. The awardee operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs through the Defense Logistics Agency's supply chain.</p>
- The Defense Logistics Agency issued a $4,966.62 delivery order to Amerisourcebergen Drug Corp on April 8, 2026, for JARDIANCE 25 mg tablets (90-count). The order is a firm fixed-price call against the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999 through December 2026, which supplies pharmaceutical products and medical commodities globally to military healthcare programs. Place of performance is Conshohocken, PA. The order completion date is April...
- The Defense Logistics Agency issued a $4,242.52 delivery order to Amerisourcebergen Drug Corp on April 7, 2026, for JARDIANCE 25 MG tablets (90-count supply), with ultimate completion by April 8, 2026. The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which provides comprehensive global pharmaceutical support to military healthcare programs. Place of performance is Conshohocken, Pennsylvania. Pricing...
- The Defense Logistics Agency issued a $2,631.88 delivery order to Amerisourcebergen Drug Corp on April 10, 2026, for JARDIANCE 10 MG TABLET 90S, with ultimate completion on April 13, 2026. The order is issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which supports pharmaceutical and medical supply deliveries to military healthcare programs globally. Place of performance is Conshohocken, PA. Pricing is firm...
- The Defense Logistics Agency issued a $6,252.74 delivery order to Amerisourcebergen Drug Corp on April 14, 2026, for JARDIANCE 10 mg tablets (90-count supply) with an ultimate completion date of April 15, 2026. The order is issued under a firm fixed-price structure with no set-aside applied. Place of performance is Conshohocken, PA. The parent vehicle is an Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which supports global...
- The Defense Logistics Agency issued a $23,334.44 delivery order to Amerisourcebergen Drug Corp on February 25, 2026, for JARDIANCE 10 mg tablets (90-count). Place of performance is Conshohocken, PA. Ultimate completion date is February 26, 2026. The order carries a firm fixed price and was issued without set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs through the Defense Logistics Agency's Troop...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F77GXDelivery Order
The Defense Logistics Agency issued a $19,052.71 delivery order to Amerisourcebergen Drug Corp on April 20, 2026, for JARDIANCE 25 mg tablets (90-count units) with an ultimate completion date of April 21, 2026. Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a pharmaceutical distributor supplying brand-name and generic medications to Defense Health Agency and military medical facilities under DLA's single-award Pharmaceutical Prime Vendor Global Program Generation V indefinite delivery contract (SPE2DX), valued at $4.999 million through December 2036.
Generated 7/19/26, 9:58 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.1k | 4/19/26 |